{
    "cancelStatus": "0",
    "cancelDate": null,
    "cancelReason": [],
    "licid": "52028680",
    "validDate": "2029-03-27 00:00:00.000",
    "issueDate": "2024-03-26 00:00:00.000",
    "licKind": "10",
    "oldLicid": null,
    "certNo": "DHA05202868008",
    "prodNameC": "煞拉速肌瘤靶泊甲苯磺酸鹽",
    "prodNameE": "Sorafenib Tosylate",
    "indicationsName": [
        "抗腫瘤藥"
    ],
    "does": "0040",
    "packageUnit": [
        {
            "packageSpec": null,
            "packageUnit": "4C"
        }
    ],
    "medMCode": "01",
    "maMedCode": null,
    "medDCode": "E",
    "ingredientsDesc": [
        null,
        "Sorafenib Tosylate contains not less than 97.0% and not more than 102.0% of C21H16CIF3N4O3·C7H8O3S."
    ],
    "restraintItemsCode": [
        "02"
    ],
    "applicantName": "川聖貿易股份有限公司",
    "applicantAddr": "台北市松山區民生東路5段28號5樓",
    "medClass": null,
    "efficacy": null,
    "mdFormat": null,
    "productAnnotation": null,
    "mdKind": [],
    "monitorDate": null,
    "licidNew": null,
    "licidOld": null,
    "factoryDtoList": [
        {
            "factoryCode": "1",
            "factoryName": "CIPLA LIMITED",
            "factoryAddr": "PLOT NO. 285, 286 & 287, BOMMASANDRA-JIGANI LINK ROAD, INDUSTRIAL AREA, KIADB, 4TH PHASE, BENGALURU 560105, KARNATAKA, INDIA",
            "factoryCompanyAddr": "",
            "countryCode": "IN",
            "processCode": [],
            "processCodeStr": null,
            "factoryKind": "M",
            "factoryNo": "FIN0815200",
            "factoryInfo": null,
            "qsd": null
        }
    ],
    "ingredientsDtoList": [
        {
            "ingredientsKind": "1",
            "ingredientsCode": null,
            "ingredientsDesc": null,
            "concentDesc": null,
            "concent": null,
            "concentUnit": null,
            "seq": "1",
            "prescription_seq": "1",
            "prescription_Kind": "1"
        },
        {
            "ingredientsKind": "1",
            "ingredientsCode": null,
            "ingredientsDesc": "Sorafenib Tosylate contains not less than 97.0% and not more than 102.0% of C21H16CIF3N4O3·C7H8O3S.",
            "concentDesc": null,
            "concent": null,
            "concentUnit": null,
            "seq": "1",
            "prescription_seq": "1",
            "prescription_Kind": "2"
        }
    ],
    "authDtoList": [
        {
            "applicantName": "丸聖貿易股份有限公司",
            "certNo": "DHA05202868019",
            "approveDocNo": "1130709964",
            "authDate": "2024-03-26",
            "validDate": "2029-03-26"
        }
    ],
    "iomDtoList": [],
    "changeDtoList": [],
    "atcList": [],
    "licBaseId": "94555928-F193-4F00-808F-A8B6F2CA0FC6"
}